Moore Capital Management’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-125,000
| Closed | -$632K | – | 382 |
|
|
2019
Q3 | $632K | Buy |
125,000
+25,000
| +25% | +$126K | 0.03% | 223 |
|
|
2019
Q2 | $617K | Hold |
100,000
| – | – | 0.01% | 236 |
|
|
2019
Q1 | $464K | Hold |
100,000
| – | – | 0.01% | 242 |
|
|
2018
Q4 | $420K | Hold |
100,000
| – | – | 0.02% | 183 |
|
|
2018
Q3 | $627K | Buy |
+100,000
| New | +$627K | 0.01% | 211 |
|
|
2014
Q1 | – | Sell |
-95,000
| Closed | -$506K | – | 489 |
|
|
2013
Q4 | $506K | Buy |
95,000
+45,000
| +90% | +$240K | 0.01% | 286 |
|
|
2013
Q3 | $252K | Buy |
+50,000
| New | +$252K | 0.01% | 276 |
|